← FDA Drug Approvals (Drugs@FDA)

SYNRIBO

NDA · New Drug Application · Sponsor: TEVA PHARMS INTL · Approved 2012-10-26

Drug application

FDA Application #

NDA203585

Application type

New Drug Application

Brand name

SYNRIBO

Generic name

Omacetaxine Mepesuccinate

Active ingredients

OMACETAXINE MEPESUCCINATE

Dosage form

POWDER

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

TEVA PHARMS INTL

First approval

2012-10-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown